Schedule 13G Filing for NexGel, Inc.
2026-03-12SEC Filing SCHEDULE 13G (0001493152-26-009776)
Asymmetry Point LP, along with its general partner Asymmetry Point Capital LLC and fund manager Mr. Aviv Argaman, has reported acquiring 610,000 shares of NexGel, Inc. common stock. This acquisition represents a 7.49% ownership stake in the company, based on a total of 8,143,133 shares outstanding as of November 12, 2025. The filing indicates that these shares were not acquired for the purpose of influencing the control of the issuer. The filing was made on March 12, 2026, with an event date of March 10, 2026. Asymmetry Point LP is a Delaware limited partnership, Asymmetry Point Capital LLC is a Florida limited liability company, and Mr. Aviv Argaman is an Israeli citizen.
Related industry:Medical Instruments & Supplies
Source:Original SEC Document β